Literature DB >> 8661109

Physical mapping and genomic structure of the human TNFR2 gene.

C P Beltinger1, P S White, J M Maris, E P Sulman, S J Jensen, D LePaslier, B J Stallard, D V Goeddel, F J de Sauvage, G M Brodeur.   

Abstract

The tumor necrosis factor receptor 2 (TNFR2) gene localizes to 1p36. 2, a genomic region characteristically deleted in neuroblastomas and other malignancies. In addition, TNFR2 is the principal mediator of the effects of TNF on cellular immunity, and it may cooperate with TNFR1 in the killing of nonlymphoid cells. Therefore, we undertook an analysis of the genomic structure and precise physical mapping of this gene. The TNFR2 gene is contained on 10 exons that span 26 kb. Most of the functional domains of TNFR2 are encoded by separate exons, and each of the repeats of the extracellular cysteine-rich domain is interrupted by an intron. The genomic structure reveals a close relationship to TNFR1, another member of the TNFR superfamily. Based on electrophoretic analysis of yeast artificial chromosomes, TNFR2 maps within 400 kb of the genetic marker D1S434. In addition, we have identified a new polymorphic dinucleotide repeat within intron 4 of TNFR2. The genetic sequence information and exon-intron boundaries we have determined will facilitate mutational analysis of this gene to determine its potential role in neuroblastoma, as well as in other cancers with characteristic deletions or rearrangements of 1p36.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661109     DOI: 10.1006/geno.1996.0327

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

Review 1.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

2.  Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome.

Authors:  J Heikkinen; T Toppinen; H Yeowell; T Krieg; B Steinmann; K I Kivirikko; R Myllylä
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

3.  CA repeat polymorphism of the TNFR2 gene is not associated with bone mineral density in two independent Caucasian populations.

Authors:  Qing-Yang Huang; Hui Shen; Hong-Yi Deng; Theresa Conway; Leo Elze; K Michael Davies; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  DNA fragmentation factor 45 (DFF45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line.

Authors:  H W Yang; Y Z Chen; H Y Piao; J Takita; E Soeda; Y Hayashi
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

5.  Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus.

Authors:  Pham Dang Khoa; Tsuyoshi Sugiyama; Takashi Yokochi
Journal:  Clin Rheumatol       Date:  2004-07-07       Impact factor: 2.980

6.  Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population.

Authors:  Lynnette R Ferguson; Dug Yeo Han; Claudia Huebner; Ivonne Petermann; Murray L Barclay; Richard B Gearry; Alan McCulloch; Pieter S Demmers
Journal:  Gastroenterol Res Pract       Date:  2009-05-03       Impact factor: 2.260

Review 7.  Systems biology applied to vaccine and immunotherapy development.

Authors:  Luigi Buonaguro; Ena Wang; Maria Lina Tornesello; Franco M Buonaguro; Francesco M Marincola
Journal:  BMC Syst Biol       Date:  2011-09-20

8.  TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Xiaoxiang Guan; Zhongxin Liao; Hongxia Ma; Ji Qian; Zhensheng Liu; Xianglin Yuan; Daniel Gomez; Ritsuko Komaki; Li-E Wang; Qingyi Wei
Journal:  BMC Cancer       Date:  2011-10-14       Impact factor: 4.430

9.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

10.  Complex genetic predisposition in adult and juvenile rheumatoid arthritis.

Authors:  Bianca Miterski; Susanne Drynda; Gundula Böschow; Wolfram Klein; Joachim Oppermann; Jörn Kekow; Jörg Thomas Epplen
Journal:  BMC Genet       Date:  2004-02-04       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.